Your browser doesn't support javascript.
Machine learning analysis of humoral and cellular responses to SARS-CoV-2 infection in young adults.
Marcinkevics, Ricards; Silva, Pamuditha N; Hankele, Anna-Katharina; Dörnte, Charlyn; Kadelka, Sarah; Csik, Katharina; Godbersen, Svenja; Goga, Algera; Hasenöhrl, Lynn; Hirschi, Pascale; Kabakci, Hasan; LaPierre, Mary P; Mayrhofer, Johanna; Title, Alexandra C; Shu, Xuan; Baiioud, Nouell; Bernal, Sandra; Dassisti, Laura; Saenz-de-Juano, Mara D; Schmidhauser, Meret; Silvestrelli, Giulia; Ulbrich, Simon Z; Ulbrich, Thea J; Wyss, Tamara; Stekhoven, Daniel J; Al-Quaddoomi, Faisal S; Yu, Shuqing; Binder, Mascha; Schultheiß, Christoph; Zindel, Claudia; Kolling, Christoph; Goldhahn, Jörg; Seighalani, Bahram Kasmapour; Zjablovskaja, Polina; Hardung, Frank; Schuster, Marc; Richter, Anne; Huang, Yi-Ju; Lauer, Gereon; Baurmann, Herrad; Low, Jun Siong; Vaqueirinho, Daniela; Jovic, Sandra; Piccoli, Luca; Ciesek, Sandra; Vogt, Julia E; Sallusto, Federica; Stoffel, Markus; Ulbrich, Susanne E.
  • Marcinkevics R; Department of Computer Science, ETH Zurich, Zurich, Switzerland.
  • Silva PN; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Hankele AK; Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland.
  • Dörnte C; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Kadelka S; Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland.
  • Csik K; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Godbersen S; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Goga A; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Hasenöhrl L; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Hirschi P; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Kabakci H; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • LaPierre MP; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Mayrhofer J; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Title AC; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Shu X; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
  • Baiioud N; Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland.
  • Bernal S; Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland.
  • Dassisti L; Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland.
  • Saenz-de-Juano MD; Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland.
  • Schmidhauser M; Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland.
  • Silvestrelli G; Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland.
  • Ulbrich SZ; Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland.
  • Ulbrich TJ; Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland.
  • Wyss T; Animal Physiology, Institute of Agricultural Sciences, ETH Zurich, Zurich, Switzerland.
  • Stekhoven DJ; NEXUS Personalized Health Technologies, Zurich & SIB Swiss Institute of Bioinformatics, ETH Zurich, Lausanne, Switzerland.
  • Al-Quaddoomi FS; NEXUS Personalized Health Technologies, Zurich & SIB Swiss Institute of Bioinformatics, ETH Zurich, Lausanne, Switzerland.
  • Yu S; NEXUS Personalized Health Technologies, Zurich & SIB Swiss Institute of Bioinformatics, ETH Zurich, Lausanne, Switzerland.
  • Binder M; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Schultheiß C; Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Zindel C; Department of Health Science, Translational Medicine, ETH Zurich, Zurich, Switzerland.
  • Kolling C; Department of Health Science, Translational Medicine, ETH Zurich, Zurich, Switzerland.
  • Goldhahn J; Department of Health Science, Translational Medicine, ETH Zurich, Zurich, Switzerland.
  • Seighalani BK; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Zjablovskaja P; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Hardung F; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Schuster M; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Richter A; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Huang YJ; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Lauer G; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Baurmann H; Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
  • Low JS; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Vaqueirinho D; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Jovic S; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Piccoli L; Humabs BioMed SA, a Subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
  • Ciesek S; Institute of Medical Virology, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Vogt JE; Department of Computer Science, ETH Zurich, Zurich, Switzerland.
  • Sallusto F; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Stoffel M; Medical Immunology, Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
  • Ulbrich SE; Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
Front Immunol ; 14: 1158905, 2023.
Article in English | MEDLINE | ID: covidwho-20239264
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces B and T cell responses, contributing to virus neutralization. In a cohort of 2,911 young adults, we identified 65 individuals who had an asymptomatic or mildly symptomatic SARS-CoV-2 infection and characterized their humoral and T cell responses to the Spike (S), Nucleocapsid (N) and Membrane (M) proteins. We found that previous infection induced CD4 T cells that vigorously responded to pools of peptides derived from the S and N proteins. By using statistical and machine learning models, we observed that the T cell response highly correlated with a compound titer of antibodies against the Receptor Binding Domain (RBD), S and N. However, while serum antibodies decayed over time, the cellular phenotype of these individuals remained stable over four months. Our computational analysis demonstrates that in young adults, asymptomatic and paucisymptomatic SARS-CoV-2 infections can induce robust and long-lasting CD4 T cell responses that exhibit slower decays than antibody titers. These observations imply that next-generation COVID-19 vaccines should be designed to induce stronger cellular responses to sustain the generation of potent neutralizing antibodies.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Front Immunol Year: 2023 Document Type: Article Affiliation country: Fimmu.2023.1158905

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Front Immunol Year: 2023 Document Type: Article Affiliation country: Fimmu.2023.1158905